Stocks Health care BWAY
NASDAQ · Health careBrainsway Ltd. (BWAY)
Brainsway Ltd. reported revenue of $41M in fiscal 2024, up 29.0% from a year earlier. Net income was $2.9M, a net margin of 7.1%. At December 31, 2024 it held $69.3M in cash. Its latest periodic report to the SEC is the annual report (foreign issuer) (20-F) filed on April 20, 2026.
Watch BWAY in 60 secondsWhat Brainsway Ltd. does
Brainsway Ltd. is registered with the SEC under industry code SIC 3841 (Surgical & Medical Instruments & Apparatus). Its shares trade on NASDAQ under the ticker BWAY.
Revenue and profit by year
Key figures
| Fiscal year | Revenue | Net income | Diluted EPS | Free cash flow |
|---|---|---|---|---|
| 2024 | $41M | $2.9M | $0.05 | n/a |
| 2023 | $31.8M | -$4.2M | -$0.13 | n/a |
| 2022 | $27.2M | -$13.3M | -$0.40 | n/a |
| 2021 | $29.7M | -$6.5M | -$0.21 | -$1.4M |
| 2020 | $22.1M | -$5.4M | -$0.24 | -$3.9M |
| 2019 | $23.1M | -$10.3M | -$0.50 | -$10.6M |
Full financial statements: income, balance sheet and cash flow
Where BWAY ranks in Health care
Latest SEC filings
What Brainsway Ltd. has filed recently, newest first. Each links to the original document on SEC EDGAR.
- September 8, 2026
- August 27, 2026
- August 12, 2026
- August 12, 2026
- July 29, 2026Passive stake changed SCHEDULE 13G/A
- July 20, 2026
- July 16, 2026
- June 29, 2026
- June 22, 2026
- June 9, 2026
Insider trades
What the people running Brainsway Ltd. did with its shares, from the Form 4 filings they must send the SEC within two business days.
No insider trades were reported in the last 90 days.
| Date | Insider | What | Shares | Value |
|---|---|---|---|---|
| June 15, 2026 | Moiseyev GiladChief Technology Officer | Sold | 5,000 | - |
| June 2, 2026 | Roth YiftachChief Scientist | Sold | 1,000 | - |
| June 2, 2026 | Roth YiftachChief Scientist | Sold | 2,000 | - |
| June 1, 2026 | Roth YiftachChief Scientist | Sold | 2,000 | - |
| June 1, 2026 | Roth YiftachChief Scientist | Sold | 2,000 | - |
| May 26, 2026 | Mitrany Rayten Michal EtyDirector | Sold | 7,980 | - |
| May 25, 2026 | Moiseyev GiladChief Technology Officer | Exercised options | 7,500 | - |
| May 25, 2026 | Moiseyev GiladChief Technology Officer | Shares withheld for tax | 1,902 | - |
| May 25, 2026 | Mitrany Rayten Michal EtyDirector | Sold | 10,000 | - |
| May 20, 2026 | Mitrany Rayten Michal EtyDirector | Exercised options | 17,500 | - |
| May 20, 2026 | Mitrany Rayten Michal EtyDirector | Shares withheld for tax | 6,080 | - |
| May 19, 2026 | Mitrany Rayten Michal EtyDirector | Exercised options | 10,000 | - |
| May 19, 2026 | Mitrany Rayten Michal EtyDirector | Shares withheld for tax | 3,440 | - |
Who owns BWAY
Three views from three kinds of SEC filings, each with its own date. They overlap and are not added up.
5% holders
| Holder | Of class | Filed |
|---|---|---|
| Jonathan Shulkin13D, may seek influence with 10 related filers | 15% | October 8, 2025 |
| Harel Insurance Investments & Financial Services Ltd.13G, passive | 8.3% | July 29, 2026 |
| Meitav Investment House Ltd13G, passive with 1 related filers | 6.31% | June 3, 2026 |
Largest institutional holders
Insiders
3 insiders reported holding 1,137,903 shares in total, about $15.1M at the last price.
| Holder | Shares |
|---|---|
| Roth YiftachChief Scientist | 1,072,305 |
| Moiseyev GiladChief Technology Officer | 53,098 |
| Mitrany Rayten Michal EtyDirector | 12,500 |
Questions about BWAY
What does Brainsway Ltd. do?
Brainsway Ltd. is registered with the SEC under industry code SIC 3841 (Surgical & Medical Instruments & Apparatus). Its shares trade on NASDAQ under the ticker BWAY.
Is Brainsway Ltd. profitable?
Yes. In fiscal 2024 it reported net income of $2.9M on revenue of $41M, a net margin of 7.1%.
How much revenue does Brainsway Ltd. make?
In fiscal 2024 Brainsway Ltd. reported revenue of $41M. That is 29.0% more than a year earlier.
When did Brainsway Ltd. last report?
Its most recent periodic report is the annual report (foreign issuer) (20-F) filed on April 20, 2026. It covers the period to December 31, 2025. Its newest filing of any kind is the foreign issuer update from September 8, 2026.
Similar companies
Compare BWAY with
Follow BWAY
Get an email when Brainsway Ltd. files with the SEC: results, executive changes, material agreements and annual reports.
Follow BWAY: get an email when it filesWhere the numbers come from
Financial figures are the values Brainsway Ltd. tagged in its own SEC filings (XBRL), taken from the latest filing for each period, so restatements replace older figures. Revenue, profit and cash flow are for full fiscal years unless marked as the last twelve months, which is the sum of the four most recent quarters. Where a company reports only the full year, the fourth quarter is the year minus the first three.
Prices are delayed end-of-day market data in the listing currency, and market cap moves with the price. P/E is shown only when earnings per share are positive. Nothing here is investment advice.